A Game-Changing Initiative Surface!

The International Vaccine Institute (IVI) and the International Centre for Antimicrobial Resistance Solutions (ICARS) have joined forces to tackle a growing health crisis in the Philippines. Their new project—"Advancing Vaccine Uptake to Mitigate Antimicrobial Resistance (AMR) in Low- and Middle-Income Countries of South or South-East Asia"—is set to transform public health strategy.

Tackling a Major Health Threat!

Led by the Ateneo School of Medicine and Public Health's Center for Research and Innovation (ACRI) along with IQVIA Solutions Philippines, this initiative addresses the alarming rise of antimicrobial resistance (AMR) in the region by enhancing vaccination efforts.

Innovative Strategies in Action!

The project's objective is clear: to devise data-driven strategies that will integrate vaccination programs with AMR control. By studying significant pathogen-vaccine combinations, including Streptococcus pneumoniae, Haemophilus influenzae, and various circulating influenza strains, they plan to leverage existing data from the Philippines' Expanded Program on Immunization and the Antimicrobial Resistance Surveillance Programme.

Vaccines: A Powerful Weapon Against AMR!

Dr. Nandini Sreenivasan, Senior Science Advisor at ICARS, emphasized the untapped potential of vaccines, stating, "Vaccines have long been recognized for their role in preventing disease, but their power to reduce antibiotic use is often overlooked." This project aims to shift that perspective by positioning vaccines at the forefront of AMR strategies in low- and middle-income countries.

The Urgent Need for Action!

In 2019 alone, about 15,700 deaths in the Philippines were directly linked to AMR. This project not only seeks to reduce these numbers by preventing infections but also aims to diminish reliance on antibiotics through effective vaccination.

Strengthening Global Health Security!

Dr. Laura Plant, Head of External Affairs at IVI's European Regional Office, added, "Strengthening vaccine uptake in LMICs is essential for safeguarding global health security." This collaborative effort showcases the critical role vaccines play in confronting AMR.

A Bright Future for Public Health!

As this groundbreaking project unfolds, it promises to inspire innovative health solutions, ultimately safeguarding millions and providing a blueprint for other regions grappling with similar challenges.